Potent questions about cannabis and mental health

This publication has 9 references indexed in Scilit:

• Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
  The Lancet Psychiatry, 2015
• Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
  Addiction, 2014
• Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children
  Psychological Medicine, 2014
• Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
  Journal of Psychopharmacology, 2012
• Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
  Translational Psychiatry, 2012
• Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
  Neuropsychopharmacology, 2010
• Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
  The British Journal of Psychiatry, 2008
• Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
  The Lancet, 2007
• The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
  Neuropsychopharmacology, 2004